Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Hikma Pharmaceuticals (HIK) Share Price

Price 1,640.00p on 25-08-2026 at 18:35:09
Change 7.00p 0.43%
Buy 1,637.00p
Sell 1,634.00p
Last Trade: Sell 395.00 at 1,640.00p
Day's Volume: 348,995
Last Close: 1,640.00p
Open: 1,635.00p
ISIN: GB00B0LCW083
Day's Range 1,625.00p - 1,644.00p
52wk Range: 1,187.00p - 1,865.00p
Market Capitalisation: £3.40b
VWAP: 1,638.29004p
Shares in Issue: 207.02m

Hikma Pharmaceuticals (HIK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 395 1,640.00p Automatic Execution
16:37:45 - 25-Aug-26
Buy* 394 1,640.00p Automatic Execution
16:37:45 - 25-Aug-26
Buy* 788 1,640.00p Automatic Execution
16:37:34 - 25-Aug-26
Buy* 1,309 1,640.00p Automatic Execution
16:37:34 - 25-Aug-26
Buy* 267 1,640.00p Automatic Execution
16:36:19 - 25-Aug-26
Sell* 2,619 1,640.00p Automatic Execution
16:36:19 - 25-Aug-26
Sell* 2,329 1,640.00p Automatic Execution
16:36:19 - 25-Aug-26
Sell* 811 1,640.00p Automatic Execution
16:36:19 - 25-Aug-26
Sell* 745 1,640.00p Automatic Execution
16:36:19 - 25-Aug-26
Sell* 1,887 1,640.00p Automatic Execution
16:36:19 - 25-Aug-26
See more Hikma Pharmaceuticals trades

Hikma Pharmaceuticals (HIK) Share Price History

Time period:
to
Date Open High Low Close Volume
24th Aug 2026 (Mon) 1,627.00 1,633.00 1,619.00 1,633.00 680,889
21st Aug 2026 (Fri) 1,620.00 1,636.00 1,608.00 1,636.00 511,535
20th Aug 2026 (Thu) 1,662.00 1,664.00 1,614.00 1,624.00 458,561
19th Aug 2026 (Wed) 1,655.00 1,667.00 1,647.00 1,658.00 567,909
18th Aug 2026 (Tue) 1,635.00 1,657.00 1,628.00 1,652.00 392,687
17th Aug 2026 (Mon) 1,646.00 1,652.00 1,631.00 1,639.00 668,271
14th Aug 2026 (Fri) 1,648.00 1,653.00 1,623.00 1,640.00 6,846,241
13th Aug 2026 (Thu) 1,638.00 1,649.00 1,622.00 1,643.00 625,585
12th Aug 2026 (Wed) 1,649.00 1,662.00 1,625.00 1,647.00 1,162,542
11th Aug 2026 (Tue) 1,655.00 1,655.00 1,618.00 1,638.00 1,011,110
10th Aug 2026 (Mon) 1,687.00 1,695.00 1,643.00 1,649.00 1,281,012
7th Aug 2026 (Fri) 1,703.00 1,723.00 1,672.00 1,677.00 910,812
6th Aug 2026 (Thu) 1,641.00 1,755.00 1,637.00 1,699.00 2,631,484
5th Aug 2026 (Wed) 1,584.00 1,597.00 1,563.00 1,571.00 2,232,879
4th Aug 2026 (Tue) 1,578.00 1,598.00 1,570.00 1,581.00 510,172
3rd Aug 2026 (Mon) 1,590.00 1,591.00 1,568.00 1,573.00 602,729
31st Jul 2026 (Fri) 1,602.00 1,602.00 1,585.00 1,585.00 639,207
30th Jul 2026 (Thu) 1,625.00 1,626.00 1,588.00 1,594.00 573,634
29th Jul 2026 (Wed) 1,600.00 1,637.00 1,600.00 1,630.00 2,067,440
28th Jul 2026 (Tue) 1,583.00 1,631.00 1,578.00 1,613.00 643,317
27th Jul 2026 (Mon) 1,593.00 1,596.00 1,572.00 1,577.00 668,535
See more Hikma Pharmaceuticals price history

Hikma Pharmaceuticals (HIK) Regulatory News

Date Source Headline
24th Aug 2026 3:03 pm RNS Director/PDMR Shareholding
24th Aug 2026 10:54 am RNS Transaction in Own Shares
17th Aug 2026 3:24 pm RNS Holding(s) in Company
17th Aug 2026 2:57 pm RNS Holding(s) in Company
17th Aug 2026 1:03 pm RNS Transaction in Own Shares
11th Aug 2026 10:49 am RNS Director/PDMR Shareholding
10th Aug 2026 10:05 am RNS Transaction in Own Shares
6th Aug 2026 7:01 am RNS Directorate change
6th Aug 2026 7:00 am RNS Half-year Financial Report
3rd Aug 2026 12:49 pm RNS Total Voting Rights
See more Hikma Pharmaceuticals regulatory news

Hikma Pharmaceuticals (HIK) Share News

LONDON BROKER RATINGS: Citigroup says 'buy' Next, UBS raises Drax

25th Aug 2026 09:34

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

DIRECTOR DEALINGS: Glanbia CFO banks EUR600,000; Hikma non-exec buys

12th Aug 2026 13:09

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Tuesday and not separately reported by Alliance News: Read More

LONDON BROKER RATINGS: Shore cuts Tesco; Davy lowers Greggs

12th Aug 2026 08:52

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

LONDON BROKER RATINGS: Goldman and UBS cut Legal & General to 'sell'

11th Aug 2026 09:37

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

LONDON BROKER RATINGS: Persimmon, Shaftesbury upped; Coca-Cola HBC cut

10th Aug 2026 09:41

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

See more Hikma Pharmaceuticals news
FTSE 100 Latest
Value10,886.16
Change31.84

Login to your account

Forgot Password?

Not Registered